Milestones, partnerships, and policy moments in the journey of the HoloMedicine® Association, from our founding to today.
After Microsoft discontinued the HoloLens in April 2024, see-through holographic hardware all but disappeared and many of the field's largest players stepped back. With Apple and Google's Android XR bringing a new generation of devices to market from December 2025, extended reality is firmly back, and the HoloMedicine® Association relaunches to lead its safe clinical adoption.
Researchers introduce a targeted augmented reality-guided transperineal prostate biopsy approach for more accurate diagnosis of prostate cancer.
The National University Health System (NUHS) in Singapore hosts a summit exploring holomedicine and 5G connectivity, with HMA, IMDA, GSMA, and NUHS.
The European Commission report explores XR opportunities, success stories, and challenges across healthcare and education.
The Association takes part in the European Health Tech Summit in the European Parliament in Brussels, hosted by MEPs Stelios Kympouropoulos and Maria da Graça Carvalho.
The Association signs a Letter of Intent with the European Space Agency (ESA).
The HoloMedicine® Association and the Society for Simulation in Healthcare sign an affiliation agreement at the International Meeting on Simulation in Healthcare in Orlando, Florida.
The Association joins the GSMA APAC 5G Industry Community ecosystem, a community of over 500 members across more than 30 countries.
GIGXR joins as an official industry sponsor, a leader in education and training using extended reality, partnering with universities including Michigan and Cambridge.
Health Education England, a national leadership organisation for education, training, and workforce development, joins as a Healthcare Institute Partner.
The Association's Policy and Advocacy Working Group develops and submits feedback to the European Health Data Space public consultation.
The National University Health System, a HoloMedicine® Centre of Excellence, receives an IMDA grant for indoor 5G deployment in operating theatres and trial wards.
Co-chairman Dr Yujia Gao speaks at the Building Digital Nations event in Singapore on advanced technologies and digital innovation across Asia Pacific.
The Association officially appoints leads and co-leads for its working groups through a democratic vote by members.
At the International Society for Minimally Invasive Cardiothoracic Surgery meeting, National University Hospital Singapore presents virtual-reality holography-guided incision placement.
The Association announces the launch of three working groups focusing on key organisational areas.
Recordings and the report from the Inaugural Summit of 27 November 2021, which brought together global experts on holomedicine, are made available.
The virtual Inaugural Summit will bring doctors and experts worldwide to showcase knowledge in healthcare, digital innovation, and technology.
The European Commission organises 'From Ambition to Action', a high-level conference promoting trustworthy AI and digital innovation in policymaking.
The JRC and OECD publish 'National strategies on Artificial Intelligence: A European perspective', comparing AI strategies across Member States.
The WHO issues its first global report on AI in health with six guiding principles in 'Ethics and Governance of Artificial Intelligence for Health'.
The OECD outlines priorities for the development and application of AI, including in clinical decision-making and research.
Holding the EU Council Presidency for the second half of 2021, Slovenia aims to reach agreement on AI among EU countries.
On World Telecommunication and Information Society Day, the Association opens to new members, advancing digital health initiatives.
The European Commission proposes harmonised AI rules to create an 'ecosystem of trust', as the AI healthcare market is predicted to exceed $61 billion within a decade.
Scotland releases an AI strategy to become a world leader in trustworthy, ethical, and inclusive AI.
Serbia leverages AI in its immunisation efforts, ranking among the leaders in Europe for COVID-19 vaccination rates.
As COVID-19 focuses attention on healthcare systems, governments and advisors prioritise attracting medical AI research and development.
Following Brexit, the UK establishes new collaborative horizons with AI research and development as a central pillar of economic collaboration.
The UK Government announces £50 million to support diagnostic centres developing AI for disease diagnosis by 2028.
Calls for regulatory oversight mount as AI-based technology innovations progress in healthcare and wider society.
The Exscalate4CoV consortium uses supercomputer-driven drug discovery to accelerate the fight against COVID-19 through EU-funded collaboration.
Telehealth gains prominence during COVID-19, providing remote and virtual healthcare through telecommunication technology.
AI demonstrates new applications in the medical imaging of COVID-19, building on proven diagnostic capabilities.
London's Middlesex University invests in VR simulation as a new teaching tool for nursing students.
The European Commission publishes its Data and AI strategy, setting out plans to expand Europe's technological and AI capacities.
The UK Health Secretary launches a £140 million AI award to bring life-saving innovation to the NHS.
